from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2370c/-

LFCtreatmentdescriptionclass of inhibitor

0.209

Amikacinug/mL Amikacintranslation

-0.376

Cap5-10ug/mL Capreomycintranslation

-1.559

Rox10-50 ug/mL Roxithromycintranslation

0.748

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.066

Rif0.2-5ug/mL Rifampicintranscription

-0.092

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.021

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.052

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.405

CPZ10-50 ug/mL Chlorpromazinerespiration

0.218

Clofazimine10-13 ug/mL Clofaziminerespiration

0.549

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.526

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.565

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.074

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.182

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.926

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.177

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.636

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.515

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.130

KCN5-20 ug/mL Potassium cyaniderespiration

0.523

NaN30.2-2 mM Sodium aziderespiration

0.985

Nigericin50 uM Nigericinrespiration

-0.051

TRC10-150 ug/mL Triclosanrespiration

-0.493

TRZ10-25 ug/mL Thioridazinerespiration

-0.048

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.681

menadione6-10 ug/mL Menadionerespiration

0.219

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.205

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.096

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.047

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.500

NRP_1Non-replicating persistence stage 1dosRassociated

-0.903

Amp0.2mg/mL AmpicillincellWall

0.161

Cephalexin20-100 ug/mL CephalexincellWall

0.854

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.365

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.115

EMB10-20 ug/mL EthambutolcellWall

1.434

Eta12-40 ug/mL EthionamidecellWall

0.724

INH0.2-0.4 ug/mL IsoniazidcellWall

1.240

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.274

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.198

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.397

BZA0.12 mg/mL BenzamidearomaticAmides

-0.543

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.714

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.212

H2O24 mM hydrogen peroxideDNAdamaging

0.240

Levo10 ug/mL LevofloxacinDNAdamaging

0.422

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.105

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.379

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.263

UVUV-irradiationDNAdamaging

-0.402

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.393

Antimycin12.5-50 ug/mL Antimycin A?

0.537

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.500

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.022

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.387

PA8240.2-2 ug/mL PA-824?

0.020

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.896

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.273

Verapamil50 uM Verapamil?

-0.033

mercaptoethanol2 mM 2-Mercaptoethanol?

1.220

methoxatin10-20 ug/mL Methoxatin?